Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia

This study has been withdrawn prior to enrollment.
(The NPs that we have been buying from a vendor show lot to lot variation. We are making our own NPs, need to characterize them before we enroll new patients.)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Richard Larson, University of New Mexico Identifier:
First received: April 18, 2011
Last updated: December 10, 2015
Last verified: December 2015
No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)